Urine Drug Testing and Pain Medication Monitoring – Rx Guardian^SM from Ameritox

Pain medication monitoring with Ameritox’s Rx Guardian^SM process goes beyond standard urine drug testing, giving clinicians added confidence in assessing whether their patients are taking medications correctly. The Rx Guardian^SM process from Ameritox, enhanced with Rx Guardian CD^SM, uses patented methods and the most comprehensive reference database of pain patients who were clinically assessed as adherent. Patients’ normalized results are compared to the reference database, providing clinicians with added assurance in assessing patients’ pain medication adherence. This helps clinicians identify potential abuse, misuse or diversion of patient medication.

Discover how Rx Guardian CD^SM can help you provide a new standard of care in treating chronic pain patients. Contact Ameritox to learn more today.